Delivery Order SPE2DB22D2006-SPE2DB25FW2EX
- Not listed
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, with a ceiling value of $24,208.25 and a period of performance through July 10, 2025. The contract is not set aside and was awarded on July 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $16,404.67 and a completion date of September 25, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM. The fixed-price contract has a ceiling value of $2,502.36 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The $3,914.14 firm fixed-price contract has a completion date of July 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The contract has a ceiling value of $1,369.89 and an ultimate completion date of August 1, 2024. This contract is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is a firm fixed-price delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,663.96, is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a $1,668.24 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM. The contract has a performance period through June 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a specialty pharmaceutical product, with a potential value of $1,570.08 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The contract has a ceiling value of $1,939.86 and is a firm fixed price contract. The award date is September 23, 2024, with an ultimate completion date of September 24, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication, with a ceiling value of $11,477.66 and a completion date of June 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2EXDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $1,165.01 and an ultimate completion date of July 3, 2025. This contract is not set-aside and was awarded on July 2, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that the company holds with DLA Troop Support Medical. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/2/25 |